Dr Abdul Mannan FRCPath FCPS I Blood🩸Doctor I [email protected]

<aside> 🎯

Purpose: This learning resource helps haemophilia nurses understand the 2025 BSH guideline on hepatitis B and C management in people with bleeding disorders. By the end, you'll be able to confidently screen, assess, refer, and support your patients through their hepatitis journey.

</aside>

📋 Quick Navigation

🗂️ Content Overview

<aside> 🔴

Foundation Knowledge

• Introduction
• Historical Context
• Hepatitis B Basics
• Hepatitis C Basics </aside>

<aside> 🟠

Clinical Testing

• HBV Blood Tests
• HCV Blood Tests
• Fibrosis Assessment
• Non-Invasive Tests </aside>

<aside> 🟢

Your Actions

• Screening Pathway
• Referral Triggers
• Surveillance
• Patient Communication </aside>

<aside> ✅

Quick Tools

• Management Checklist
• Clinical Scenarios
• Follow-Up Pathway
• Summary </aside>

Introduction: Understanding Why This Matters

<aside> 💔

The Tragic History: Between the mid-1970s and early 1990s, blood products meant to help people with bleeding disorders became contaminated with hepatitis B, hepatitis C, and HIV.

</aside>

UK Impact Numbers

Today's Risk: Less than 1 in a million from UK blood products

But many of your patients are living with the long-term consequences of those historical infections:

• Some cleared the virus years ago
• Others received treatment more recently
• A few might still have active infection without knowing it

<aside> ⭐

Your Unique Position: As a haemophilia nurse, you're perfectly placed to ensure these patients get the screening, monitoring, and specialist care they need.

</aside>

The Historical Context: What Happened and Why It Still Matters